Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
Cigarette smoking is the most preventable cause of illness, death, and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this third article in our series on smoking cessation in primary care, we look at the evidence for the use of nicotinic par...
Main Authors: | Aveyard, P, Parsons, A, Begh, R |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2009
|
פריטים דומים
-
An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
מאת: Kacper Więcław, et al.
יצא לאור: (2023-08-01) -
The place of varenicline in smoking cessation treatment.
מאת: Aveyard, P
יצא לאור: (2008) -
Smoking cessation 4: Antidepressants for smoking cessation - Bupropion and nortriptyline
מאת: Aveyard, P, et al.
יצא לאור: (2010) -
Placebo-controlled trial of cytisine for smoking cessation.
מאת: West, R, et al.
יצא לאור: (2011) -
Nicotine receptor partial agonists for smoking cessation
מאת: Livingstone-Banks, J, et al.
יצא לאור: (2023)